Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao ORCID: 0000-0002-5489-6450, Reynolds, Helen ORCID: 0000-0001-7443-4520, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan
et al (show 18 more authors) (2022) 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. LANCET HIV, 9 (8). E534-E543.


Griffiths, Gareth O, FitzGerald, Richard, Jaki, Thomas, Corkhill, Andrea, Reynolds, Helen ORCID: 0000-0001-7443-4520, Ewings, Sean, Condie, Susannah, Tilt, Emma, Johnson, Lucy, Radford, Mike
et al (show 27 more authors) (2021) AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. TRIALS, 22 (1). 487-.


Kintu, Kenneth, Malaba, Thokozile, Nakibuka, Jesca, Papamichael, Christiana, Colbers, Angela, Byrne, Kelly, Seden, Kay, Hodel, Eva Maria ORCID: 0000-0001-5821-1685, Chen, Tao ORCID: 0000-0002-5489-6450, Twimukye, Adelline
et al (show 11 more authors) (2020) Dolutegravir versus efavirenz when starting HIV therapy in late pregnancy: a randomised controlled trial. The Lancet HIV, 7 (5). e332-e339.


Walker, Lauren E ORCID: 0000-0002-3827-4387, FitzGerald, Richard, Saunders, Geoffrey, Lyon, Rebecca, Fisher, Michael, Martin, Karen, Eberhart, Izabela, Woods, Christie, Ewings, Sean, Hale, Colin
et al (show 23 more authors) (2022) An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2. CLINICAL PHARMACOLOGY & THERAPEUTICS, 111 (3). pp. 585-594.

This list was generated on Sat Apr 27 02:50:46 2024 BST.